<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1152/physiol.00011.2022</dc:identifier><dc:language>eng</dc:language><dc:creator>Richardson, Katlyn C.</dc:creator><dc:creator>Jung, Karen</dc:creator><dc:creator>Pardo, Julian</dc:creator><dc:creator>Turner, Christopher T.</dc:creator><dc:creator>Granville, David J.</dc:creator><dc:title>Noncytotoxic Roles of Granzymes in Health and Disease</dc:title><dc:identifier>ART-2022-131376</dc:identifier><dc:description>Granzymes are serine proteases previously believed to play exclusive and somewhat redundant roles in lymphocyte-mediated target cell death. However, recent studies have challenged this paradigm. Distinct substrate profiles and functions have since emerged for each granzyme while their dysregulated proteolytic activities have been linked to diverse pathologies.</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/127889</dc:source><dc:doi>10.1152/physiol.00011.2022</dc:doi><dc:identifier>http://zaguan.unizar.es/record/127889</dc:identifier><dc:identifier>oai:zaguan.unizar.es:127889</dc:identifier><dc:identifier.citation>PHYSIOLOGY 37, 6 (2022), 323-348</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>